TK 112690

Drug Profile

TK 112690

Alternative Names: METREXASSISTTM; TK-112690

Latest Information Update: 09 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tosk
  • Class Chemoprotectants; Enzymes
  • Mechanism of Action Uridine phosphorylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Mucositis

Most Recent Events

  • 05 Jun 2017 Phase-I clinical trials in Mucositis (Chemotherapy-induced, Combination therapy, In adults, In the elderly) in USA (IV) (CTRI2017-05-008587)
  • 30 May 2017 Tosk plans a phase Ib trial for Mucositis (Combination therapy, Chemotherapy-induced, In adults, In the elderly) in India (IV) (CTRI/2017/05/008587)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top